Direct answer: Is it feasible for families with genetic diseases to have a healthy baby in Georgia through third-generation IVF?
Yes. For genetic diseases with a clear pathogenic gene (such as thalassemia, spinal muscular atrophy, hereditary deafness, Huntington's disease, certain chromosomal translocations, etc.), regular reproductive centers in Georgia can screen embryos using third-generation IVF (PGT, i.e., preimplantation genetic testing) technology, select embryos that do not carry the pathogenic gene for transfer, and thus give birth to healthy offspring. Georgian law allows PGT for medical indications, and the laboratories have the corresponding testing capabilities.
Doctor's perspective: Genetic counseling is a prerequisite, and not all genetic diseases are suitable
Types of genetic diseases suitable for PGT
- Single-gene genetic diseases: clear pathogenic gene, clear inheritance pattern (autosomal dominant, recessive, X-linked).
- Chromosomal structural abnormalities: such as reciprocal translocation, Robertsonian translocation, inversion, etc., leading to recurrent miscarriage or birth defects.
- Mitochondrial genetic diseases (evaluation required based on mutation type).
Unsuitable or cautionary situations
- Pathogenic gene is unclear or there is a de novo mutation that cannot be located.
- Mosaic mutation (may be missed by embryo biopsy).
- Polygenic genetic diseases (no mature PGT protocol currently available).
- Advanced age combined with genetic disease (comprehensive evaluation of the impact of embryo biopsy on survival rate required).
Doctor's advice: You must first complete family pedigree analysis at a domestic authoritative genetic counseling clinic to determine whether PGT conditions are met.
Differences between countries: Why choose Georgia? Comparison with other countries
| Country | Legal restrictions on PGT | Typical cost (one cycle) | Waiting time | Applicable genetic diseases |
|---|---|---|---|---|
| Georgia | PGT (PGT-A/PGT-M) allowed for medical reasons | 80,000-120,000 RMB | 1-2 months (genetic material review required before stimulation) | Covers common single-gene diseases and chromosomal abnormalities |
| USA | Restricted in some states, specific clinics required | 200,000-350,000 RMB | 2-4 months (visa and waiting list) | Widest range |
| Thailand | PGT-SR and PGT-M allowed, sex selection prohibited | 150,000-250,000 RMB | 1-3 months | Common genetic diseases, minor language communication |
| Domestic public hospitals | Only specific hospitals qualified to perform PGT, requires approval | 30,000-60,000 RMB (but longer cycle) | 6-12 months waiting for approval | Limited to confirmed genetic diseases |
Advantages of Georgia: relatively low cost, clear laws, embryos can be transported across borders (some clinics offer this). Disadvantages: detection depth for rare genetic diseases may not be as good as top centers in Europe and America.
Actual process: Complete path from domestic consultation to transfer
Phase 1: Domestic preparation (1-3 months)
- Genetic counseling: Identify the pathogenic gene, mutation site, and inheritance pattern.
- Family verification: Some Georgian centers require carrier verification reports from both partners and immediate family members (e.g., parents).
- Basic fertility assessment: Female AMH, antral follicle count, hormone panel; male semen analysis (including sperm DNA fragmentation index).
- Infectious disease screening: HIV, syphilis, hepatitis B, hepatitis C, etc. (valid for 3-6 months).
- Document translation and notarization: All genetic test reports, ID cards, marriage certificates (some centers require parentage notarization).
Phase 2: Cycle in Georgia (approximately 2-4 weeks)
- Contract signing and registration: Sign a treatment agreement with the hospital, confirm the PGT testing protocol (PGT-A or PGT-M).
- Ovarian stimulation: About 10-12 days, follicle monitoring every 2-3 days.
- Egg retrieval: Transvaginal egg retrieval, simultaneous sperm collection.
- Embryo culture: To cleavage or blastocyst stage.
- Embryo biopsy + testing: Results take about 7-14 days (PGT-M usually 14 days, PGT-A 7 days).
- Transfer: Select an embryo that is chromosomally normal and does not carry the pathogenic gene for transfer.
Phase 3: Follow-up (1-2 months)
- Luteal phase support: Continue medication after transfer until pregnancy test.
- Pregnancy confirmation: Blood test and ultrasound.
- Prenatal diagnosis: Chorionic villus sampling or amniocentesis recommended to verify embryo test results.
Cost factors: How much does one PGT cycle in Georgia cost?
The basic cost is generally 80,000-120,000 RMB, but the following factors can increase it:
- Custom probe development for PGT-M: Some rare genetic diseases require custom probes, costing about 20,000-50,000 RMB.
- Multiple egg retrievals: If the number of eggs retrieved is low or embryo development is poor, additional cycles may be needed.
- Embryo freezing + thawing: If fresh embryo transfer is canceled, additional freezing fees apply.
- Medical translation/escort: Non-English speaking patients often require intermediary translation services (English proficiency in Georgian medical settings is average).
- Accommodation and transportation: Local living costs are about 3,000-5,000 RMB per month.
Common pitfalls: Five frequent mistakes
- Going abroad without domestic genetic counseling: Georgian doctors cannot determine if the pathogenic gene is suitable for PGT; if conditions are not met, the cycle is wasted.
- Ignoring karyotype analysis: Some couples themselves carry chromosomal inversions or balanced translocations, requiring PGT-SR rather than just PGT-A.
- Insufficient number of embryos for testing: Most genetic diseases require 5-8 blastocysts to obtain 1-2 normal embryos; success rates drop sharply with few eggs.
- Confusing PGT-A with PGT-M: PGT-A only checks chromosome number, not gene point mutations; PGT-M checks for single-gene diseases.
- Believing success rate promises: No legitimate center guarantees 100% birth of a healthy baby; PGT has a detection error rate (about 1%-2%).
Frequently asked questions
Q1: How long does it take to do PGT in Georgia?
From the first consultation to transfer, if all goes smoothly, about 3-4 months; if no usable normal embryos are available after egg retrieval, a repeat cycle may be needed, extending the time to over six months.
Q2: Is PGT technology in Georgia reliable?
Major reproductive centers use NGS (next-generation sequencing) platforms, with detection accuracy consistent with mainstream Europe and America. However, it is necessary to confirm whether the laboratory has CAP/ISO certification.
Q3: If one partner has a genetic disease but uses donor sperm/eggs, is PGT still needed?
If using donor eggs/sperm, PGT-M is usually not needed, but PGT-A can be done to screen for embryo euploidy.
Q4: How are surplus normal embryos handled after testing?
They can be cryopreserved, with an annual storage fee (about 1,000-2,000 RMB). They can also be donated for research or destroyed, but a consent form must be signed.
Practitioner observation: Real images of similar cases in the past three years
Among families with genetic diseases seen at Georgian reproductive centers, about 40% are from China, with the main diseases being thalassemia, balanced chromosomal translocation, and spinal muscular atrophy. About 70% of cycles can obtain at least one normal embryo. However, it should be noted that if the female age is over 38 and she also carries a genetic disease, the normal embryo rate may be less than 10%. Additionally, Georgia has strict regulations on cross-border embryo transport—if you plan to bring embryos back to China for transfer, you need to understand Chinese customs and hospital policies in advance; currently, very few domestic hospitals can receive overseas embryos.
Risk reminders
- PGT itself has a certain rate of damage to embryos (about 1%-3%), with embryo development arrest after biopsy or failure to revive after thawing.
- Test results cannot cover all genetic diseases, and there is a possibility of missing very rare mutations.
- After transfer, there are routine risks such as preterm birth, miscarriage, and pregnancy complications, similar to natural pregnancy.
- Choosing unregulated intermediaries or illegal laboratories may pose risks such as embryo mix-ups or data falsification.
- It is recommended to choose centers with international reproductive society certification, publicly transparent success rate data, and keep all original genetic test reports.
Comments (0)